Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Aren’t Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore

Is Amarin Corporation plc (ADR) (NASDAQ:AMRN) a buy?

In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement. At Insider Monkey, our research analyses have shown that, historically, those who follow the top picks of the top hedge fund managers can beat the S&P 500 by a significant amount (see just how much).

Amarin Corporation plc (ADR) (NASDAQ:AMRN)

Just as crucial, bullish insider trading sentiment is another way to analyze the financial markets. There are a number of incentives for an upper level exec to cut shares of his or her company, but just one, very obvious reason why they would behave bullishly. Many empirical studies have demonstrated the useful potential of this strategy if you understand where to look (learn more here).

What’s more, let’s analyze the latest info surrounding Amarin Corporation plc (ADR) (NASDAQ:AMRN).

Hedge fund activity in Amarin Corporation plc (ADR) (NASDAQ:AMRN)

In preparation for the third quarter, a total of 15 of the hedge funds we track were long in this stock, a change of -21% from one quarter earlier. With hedgies’ capital changing hands, there exists a select group of notable hedge fund managers who were increasing their holdings considerably.

When using filings from the hedgies we track, Wojciech Uzdelewicz’s Espalier Global Management had the largest call position in Amarin Corporation plc (ADR) (NASDAQ:AMRN), worth close to $12.5 million, comprising 0.9% of its total 13F portfolio. Coming in second is Jerome Pfund and Michael Sjostrom of Sectoral Asset Management, with a $10.5 million position; the fund has 0.3% of its 13F portfolio invested in the stock. Other peers that are bullish include Charles Clough’s Clough Capital Partners, and Steven Cohen’s SAC Capital Advisors.

As Amarin Corporation plc (ADR) (NASDAQ:AMRN) has faced bearish sentiment from the top-tier hedge fund industry, it’s safe to say that there exists a select few fund managers that slashed their entire stakes heading into Q2. At the top of the heap, JΘr⌠me Pfund and Michael Sj÷str÷m’s Sectoral Asset Management dumped the largest investment of all the hedgies we key on, comprising about $13.4 million in stock. James E. Flynn’s fund, Deerfield Management, also cut its stock, about $11.6 million worth. These bearish behaviors are intriguing to say the least, as total hedge fund interest dropped by 4 funds heading into Q2.

How have insiders been trading Amarin Corporation plc (ADR) (NASDAQ:AMRN)?

Insider buying is best served when the company in question has experienced transactions within the past half-year. Over the last six-month time frame, Amarin Corporation plc (ADR) (NASDAQ:AMRN) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Amarin Corporation plc (ADR) (NASDAQ:AMRN). These stocks are Taro Pharmaceutical Industries Ltd. (NYSE:TARO), Simcere Pharmaceutical Group (ADR) (NYSE:SCR), Orexigen Therapeutics, Inc. (NASDAQ:OREX), The Medicines Company (NASDAQ:MDCO), and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). This group of stocks belong to the drug manufacturers – other industry and their market caps are similar to AMRN’s market cap.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.